Understanding and predicting bacterial infections in hospitals during COVID-19.
Official title: RFA-CK20-003: Analysis and Simulation of Bacterial Infections and Resource Strain in Hospitals during the COVID-19 Pandemic
Funded at Columbia University Health Sciences · NIH-11031920 · Data updated 2026-11-12
This study is looking at how to predict and manage infections that are resistant to antibiotics in hospitals, especially during the COVID-19 pandemic, so that doctors can better protect patients like you from these infections.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $258,328 |
| NIH project number | 5U01CK000592-05 |
| Project ID | NIH-11031920 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include hospitalized patients who are at risk of acquiring antimicrobial-resistant infections.
✕Less likely to help
Patients who are not hospitalized or do not have a risk of infection from antimicrobial-resistant pathogens may not benefit from this research.
What this research studies
This research focuses on developing advanced models to simulate and forecast outbreaks of antimicrobial-resistant (AR) infections in hospitals, particularly during the COVID-19 pandemic. By analyzing hospitalization records and diagnostic data from major hospitals in New York City, the project aims to identify individual patient risks and optimal intervention strategies. The researchers will create two types of mathematical models: one that simulates infection dynamics across multiple healthcare facilities and another that tracks individual patient movements and infection status. This approach will help healthcare providers better manage and prevent healthcare-associated infections.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and controlling bacterial infections in healthcare settings, ultimately enhancing patient safety.
How similar studies have gone: Other research has shown success in using mathematical modeling to predict infectious disease outbreaks, indicating that this approach has potential for impactful results.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Shaman, Jeffrey L — Columbia University Health Sciences
- Study coordinator: Shaman, Jeffrey L
Related research
Other NIH-funded projects on the same topics.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
COVID-19 healthcare disruptions and heart health inequities in NYC adults with multiple conditions
This project looks at how COVID-19-related gaps in care affected heart health in adults with several chronic conditions in New York City.
-
Modifying body fat to aid COVID-19 recovery through behavioral strategies
A study in veterans explores whether changing weight through lifestyle habits can improve recovery after COVID-19–related health problems.
-
Post-COVID Neuro-Cognitive Changes in Older African Americans
A study explores how COVID-19 affects thinking, memory, and daily life in older African American adults and what might be driving these changes.
-
How COVID school closures affected kids with or at risk for developmental differences
This NIH grant follows children aged 4 to 15 and their families to see how pandemic school closures impacted emotional well-being and parenting over three years.
-
Long-term COVID-19 effects in older Veterans and a rehabilitation approach
This project looks at how COVID-19 affects blood vessel health in older Veterans and tests a rehab strategy together with a mitochondria-targeted antioxidant to help recovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.